Reach Us +44-1647-403003
Kaiso As Prognosis Marker Of Patients With Chronic Myeloid Leukemia | 15866
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Kaiso as prognosis marker of patients with chronic myeloid leukemia

3rd World Congress on Cancer Science & Therapy

Jaime Cofre and Adhelay Eliana

ScientificTracks: J Cancer Sci Ther

DOI: 10.4172/1948-5956.S1.028

Kaiso protein has been identified as a new member of the POZ-ZF subfamily of transcription factors that are involved in development and cancer. There is consistent evidence of the role of Kaiso and its involvement in human tumorigenesis but there is no evidence about its role in hematopoietic differentiation or establishment of chronic myeloid leukemia (CML). We used, normal K562 cell line, imatinib-resistant K562 cell line and bone marrow from patients in chronic and blastic phase of CML (CML-BP) to investigate the specific distribution of Kaiso and their role in the progression disease. Surprisingly our results suggest that cytoplasmic localization of Kaiso is related to a poor prognosis in patients with CML-BP.
Jaime Cofre, graduated in biology in the Pontifical Catholic University of Chile and received the Ph.D. in biophysics from the University Federal of the Rio de Janeiro, now is an Associate Professor of the embryology, head of the Molecular Embryology and Cancer Research Laboratory, Chairman of Education Board of Faculty of the Medicine at University Federal of Santa Catarina. He got his B.Sc. in Biology, M.Sc. in Molecular Biology and is a specialist in Molecular Embriology and Cancer. Currently his researches focus on the epigenetic machinery responsible for cancer and specifically on the role of non canonical wnt pathways and Kaiso/p120/cadherin as prognosis markers of cancer .
Relevant Topics